In this work, the GSH/NIR sequentially initiated gas nanoadjuvant with AIEgen-mediated PDT/PTT synergistic therapy and tumor-specific amplified H2S/CO/Mn2+ generation is constructed to effectively invade cancer cells and significantly activate cGAS-STING pathway for poorly immunogenic TNBC treatment. The gene discussed is STING1; the disease is neoplasm.